BridgeBio Pharma, Inc. remains a Buy, driven by Attruby’s strong U.S. launch and favorable competitive dynamics. Learn more ...

We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and BridgeBio Pharma, Inc. (NASDAQ:BBIO) ranks 2nd on this list. BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a relatively ...

Semaglutide is a drug used for type 2 diabetes, weight loss, and more. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you ...

In "My Game: Tiger Woods-Shot making Secrets," produced by Golf Digest, Tiger takes you through his bag from the driver to the wedges. He explains his strategies, evaluates dozens of shots, and ...

Eylea (aflibercept) injections can cause both mild and serious side effects, though serious side effects are rare according to clinical trials. Mild side effects include eye floaters, redness, and ...

The successful commercialization of Attruby could establish BridgeBio as a key player in the ATTR-CM market, significantly improving its path to profitability.